Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer. uri icon

authors

  • Francis, Katherine Elizabeth
  • Cecere, Sabrina Chiara
  • Tasca, Giulia
  • Gropp-Meier, Martina
  • Fujiwara, Keiichi
  • Lowe, Elizabeth S
  • Friedlander, Michael
  • Pujade-Lauraine, Eric
  • Lee, Chee Khoon
  • Simon, Sandy
  • Gebski, Val
  • Joly, Florence
  • Ledermann, Jonathan A
  • Penson, Richard T
  • Oza, Amit M
  • Korach, Jacob
  • Lainez, Nuria

publication date

  • November 12, 2024